Home » Newsletters » BioWorld

BioWorld

Aug. 20, 1999

View Archived Issues

European Patent Disclosures

Cypros' Phase III Design OK'd; Start Will Wait On Partnership

Other News To Note

Micrologix Raises $10M Through Private Financing

Stock Jumps On Phase III Data From CV Therapeutics

Cel-Sci Wants To See Cash Before Considering $124M Offer

Sensitivity To Effects Of Estrogen May Depend On Strain Of Mouse Tested